ZA200800285B - Formulations for enhanced mucosal delivery of pyy - Google Patents
Formulations for enhanced mucosal delivery of pyyInfo
- Publication number
- ZA200800285B ZA200800285B ZA200800285A ZA200800285A ZA200800285B ZA 200800285 B ZA200800285 B ZA 200800285B ZA 200800285 A ZA200800285 A ZA 200800285A ZA 200800285 A ZA200800285 A ZA 200800285A ZA 200800285 B ZA200800285 B ZA 200800285B
- Authority
- ZA
- South Africa
- Prior art keywords
- pyy
- formulations
- mucosal delivery
- enhanced mucosal
- enhanced
- Prior art date
Links
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US69805205P | 2005-07-11 | 2005-07-11 |
Publications (1)
Publication Number | Publication Date |
---|---|
ZA200800285B true ZA200800285B (en) | 2009-08-26 |
Family
ID=39962912
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ZA200800285A ZA200800285B (en) | 2005-07-11 | 2008-01-09 | Formulations for enhanced mucosal delivery of pyy |
Country Status (2)
Country | Link |
---|---|
CN (1) | CN101262888A (en) |
ZA (1) | ZA200800285B (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104371005A (en) * | 2014-11-14 | 2015-02-25 | 中山大学 | Polypeptide PP3 capable of promoting growth hormone of tilapia mossambica to express and application of polypeptide PP3 |
-
2006
- 2006-07-10 CN CNA2006800332373A patent/CN101262888A/en active Pending
-
2008
- 2008-01-09 ZA ZA200800285A patent/ZA200800285B/en unknown
Also Published As
Publication number | Publication date |
---|---|
CN101262888A (en) | 2008-09-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GB2435419B (en) | Formulations | |
PL1888031T3 (en) | Glp-1 analogue formulations | |
EP2046930A4 (en) | Rhamnolipid-based formulations | |
HK1152478A1 (en) | Solid pharmaceutical formulations comprising bibw 2992 | |
IL188448A0 (en) | Formulations for enhanced mucosal delivery of pyy | |
HRP20130109T1 (en) | Caspofungin formulations | |
GB0605780D0 (en) | Formulations | |
HK1180949A1 (en) | Long lasting drug formulations | |
EP1888036A4 (en) | Compositions for drug delivery | |
IL194366A0 (en) | Solid dosage formulations | |
GB0618697D0 (en) | Formulations | |
EP2001400A4 (en) | Oral formulations of glycyl-2-methylprolyl-glutamate | |
GB0610336D0 (en) | Formulations | |
GB0615108D0 (en) | Novel formulations | |
ZA200807486B (en) | Medicament formulations comprising fluoroquinolones | |
EP1841451A4 (en) | Peptides for delivery of mucosal vaccines | |
IL198760A0 (en) | Oral formulations | |
IL198160A0 (en) | Pharmaceutical formulations | |
ZA200800285B (en) | Formulations for enhanced mucosal delivery of pyy | |
GB0718404D0 (en) | Formulations | |
ZA200807682B (en) | Novel formulations | |
GB0615461D0 (en) | Pharmaceutical formulations | |
GB0623791D0 (en) | Formulations | |
GB0618691D0 (en) | Formulations | |
GB0611519D0 (en) | Formulations |